wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42874199-8EAB4F9C-85C9-4758-B777-1EF07C4941E2
Q42874199-8EAB4F9C-85C9-4758-B777-1EF07C4941E2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42874199-8EAB4F9C-85C9-4758-B777-1EF07C4941E2
Phase II trial of ponatinib in patients with chronic myeloid leukemia resistant to one previous tyrosine kinase inhibitor.
P2860
Q42874199-8EAB4F9C-85C9-4758-B777-1EF07C4941E2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42874199-8EAB4F9C-85C9-4758-B777-1EF07C4941E2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0c82d94be5b89c3725c905282689814e7dd88ad4
P2860
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.